6533b86dfe1ef96bd12caae8
RESEARCH PRODUCT
Incidence, Predictors, and Impact on Six-Month Mortality of Three Different Definitions of Contrast-Induced Acute Kidney Injury After Coronary Angiography.
Charles MarcucciB. GuillonMarc BadozFiona EcarnotRomain ChopardDidier DuclouxFrancois SchieleB. BonnetMarion ChatotNicolas MeneveauPierre Freysubject
Malemedicine.medical_specialtyAcute coronary syndromemedicine.medical_treatmentPopulationRenal functionContrast Media030204 cardiovascular system & hematologyCoronary Angiography03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRisk FactorsInternal medicineCause of DeathmedicineRisk of mortalityHumans030212 general & internal medicineAcute Coronary SyndromeMortalityeducationAgededucation.field_of_studybusiness.industryIncidenceHazard ratioAcute kidney injuryPercutaneous coronary interventionAcute Kidney InjuryMiddle Agedmedicine.diseaseConfidence intervalCreatinineCardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessGlomerular Filtration Ratedescription
We assessed incidence, predictors, and impact on 6-month mortality of contrast-induced acute kidney injury (CI-AKI) after coronary angiography with or without percutaneous coronary intervention in patients with acute coronary syndrome (ACS), according to 3 different CI-AKI definitions. Serum creatinine (sCr) was assessed at baseline and 48 to 72 hours after procedure to classify patients into 3 CI-AKI groups: Group 1: increase in sCR ≥25% over baseline but absolute increase 25% in the remaining 844 (84.2%). CI-AKI was significantly associated with 6-month all-cause mortality using the definitions for Group 2 (hazard ratio 3.1, 95% confidence interval [CI] 1.5 to 6.6, p = 0.002) and Group 3 (hazard ratio 2.03, 95% CI 1.03 to 4.0, p = 0.04), but not Group 1. In conclusion, based on the definition used for CI-AKI, CI-AKI is observed in 6% to 15.7% of patients. An increase of 25% over baseline sCr does not identify high-risk patients. CI-AKI defined as an increase in sCr >0.3 mg/dl identifies 15.7% of the population at 2-fold higher risk of mortality.
year | journal | country | edition | language |
---|---|---|---|---|
2017-10-13 | The American journal of cardiology |